Nadler MB - Search Results

1

Network Meta-analysis Comparing Efficacy, Safety and Tolerability of Anti-PD-1/PD-L1 Antibodies in Solid Cancers.

Al-Showbaki L, Nadler MB, Desnoyers A, Almugbel FA, Cescon DW, Amir E. Al-Showbaki L, et al. Among authors: nadler mb. J Cancer. 2021 May 19;12(14):4372-4378. doi: 10.7150/jca.57413. eCollection 2021. J Cancer. 2021. PMID: 34093837 Free PMC article.

2

The Effect of Exercise on Quality of Life, Fatigue, Physical Function, and Safety in Advanced Solid Tumor Cancers: A Meta-analysis of Randomized Control Trials.

Nadler MB, Desnoyers A, Langelier DM, Amir E. Nadler MB, et al. J Pain Symptom Manage. 2019 Nov;58(5):899-908.e7. doi: 10.1016/j.jpainsymman.2019.07.005. Epub 2019 Jul 15. J Pain Symptom Manage. 2019. PMID: 31319105 Free article. Review.

3

A critique of the fragility index.

Desnoyers A, Nadler MB, Wilson BE, Amir E. Desnoyers A, et al. Among authors: nadler mb. Lancet Oncol. 2019 Oct;20(10):e552. doi: 10.1016/S1470-2045(19)30583-2. Epub 2019 Sep 30. Lancet Oncol. 2019. PMID: 31578994 No abstract available.

4

Influence of Competing Risks on Estimates of Recurrence Risk and Breast Cancer-specific Mortality in Analyses of the Early Breast Cancer Trialists Collaborative Group.

Saleh RR, Nadler MB, Desnoyers A, Rodin DL, Abdel-Qadir H, Amir E. Saleh RR, et al. Among authors: nadler mb. Sci Rep. 2020 Mar 5;10(1):4091. doi: 10.1038/s41598-020-61093-0. Sci Rep. 2020. PMID: 32139756 Free PMC article.

5

Comparison of treatment-related adverse events of different Cyclin-dependent kinase 4/6 inhibitors in metastatic breast cancer: A network meta-analysis.

Desnoyers A, Nadler MB, Kumar V, Saleh R, Amir E. Desnoyers A, et al. Among authors: nadler mb. Cancer Treat Rev. 2020 Nov;90:102086. doi: 10.1016/j.ctrv.2020.102086. Epub 2020 Aug 17. Cancer Treat Rev. 2020. PMID: 32861975

6

Fragility index of trials supporting approval of anti-cancer drugs in common solid tumours.

Desnoyers A, Wilson BE, Nadler MB, Amir E. Desnoyers A, et al. Among authors: nadler mb. Cancer Treat Rev. 2021 Mar;94:102167. doi: 10.1016/j.ctrv.2021.102167. Epub 2021 Feb 16. Cancer Treat Rev. 2021. PMID: 33652263 Review.

7

Fragility of randomized trials supporting cancer drug approvals stratified by approval pathway and review designations.

Wilson BE, Desnoyers A, Nadler MB, Tibau A, Amir E. Wilson BE, et al. Among authors: nadler mb. Cancer Med. 2021 Aug;10(16):5405-5414. doi: 10.1002/cam4.4029. Epub 2021 Jul 28. Cancer Med. 2021. PMID: 34323019 Free PMC article.

8

Patient and provider determinants of breast cancer screening among Ontario women aged 40-49: a population-based retrospective cohort study.

Nadler MB, Ivers N, Marchand-Austin A, Lofters A, Austin PC, Wilson BE, Desnoyers A, Amir E. Nadler MB, et al. Breast Cancer Res Treat. 2021 Oct;189(3):631-640. doi: 10.1007/s10549-021-06344-y. Epub 2021 Aug 19. Breast Cancer Res Treat. 2021. PMID: 34414531

9

Quantifying Withdrawal of Consent, Loss to Follow-Up, Early Drug Discontinuation, and Censoring in Oncology Trials.

Wilson BE, Nadler MB, Desnoyers A, Amir E. Wilson BE, et al. Among authors: nadler mb. J Natl Compr Canc Netw. 2021 Sep 3;19(12):1433-1440. doi: 10.6004/jnccn.2021.7015. J Natl Compr Canc Netw. 2021. PMID: 34479210

10

Platinum-based chemotherapy in early-stage triple negative breast cancer: A meta-analysis.

Saleh RR, Nadler MB, Desnoyers A, Meti N, Fazelzad R, Amir E. Saleh RR, et al. Among authors: nadler mb. Cancer Treat Rev. 2021 Nov;100:102283. doi: 10.1016/j.ctrv.2021.102283. Epub 2021 Aug 28. Cancer Treat Rev. 2021. PMID: 34530283

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters